Beacon Pointe Advisors’s IO Biotech IOBT Stock Holding History

Beacon Pointe Advisors’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42,600	Closed	-$2.5K	–	1984
2026 Q1	$2.5K	Sell	42,600 -463,400	-92%	-$158K	﹤0.01%	1828
2025 Q4	$308K	Buy	+506,000	New	+$376K	﹤0.01%	1252

Beacon Pointe Advisors's IOBT Position: Q2 2026 in Review

Beacon Pointe Advisors sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 42,600 shares — an estimated $2.5K sold.

Beacon Pointe Advisors first reported a position in IOBT in Q4 2025 and held it in 2 quarters. The position peaked at $308K in Q4 2025. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.

Beacon Pointe Advisors reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
Beacon Pointe Advisors sold 42,600 IO Biotech shares in Q2 2026, an estimated $2.5K.
Beacon Pointe Advisors first reported a position in IO Biotech in Q4 2025 and held it in 2 quarters.
Beacon Pointe Advisors's IO Biotech position peaked at $308K in Q4 2025.
0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.